Information Provided By: 
Fly News Breaks for July 20, 2016
SPLK
Jul 20, 2016 | 06:29 EDT
Citi analyst Walter Pritchard downgraded Splunk to Neutral citing a lack of upside to his unchanged price target of $62. The shares are under "significant pressure to continue to justify multiples on the basis of pure top-line growth," Pritchard tells investors in a research note.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
